StockGlow

Hanall Biopharma Co., Ltd. (009420.KS)

Hanall Biopharma Co., Ltd., a pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.

43,400.00+0.11%Healthcare
Compare 009420.KS with
StockGlow Score
33
Leaning Bearish
BearishBullish
1 year ago+68.9%

The outlook

Hanall Biopharma Co., Ltd. currently reads as leaning bearish based on below its 50- & 200-day averages, 38% of the way from its 52-week low to high, avg target +107% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range38% of the way from its 52-week low to high
Price targetAvg target +107% vs current price

Analyst price target

~12-month · 6 analysts
90,000.00average target+107.4% vs now
Now 43,400.00
Low 70,000.00High 130,000.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$2.21T
52-wk high
73,000.00
52-wk low
25,550.00
50-day avg
53,940.00
200-day avg
49,735.75
Trailing P/E
—

Similar stocks

008930.KSHanmi Science Co., Ltd.$35,850.00+3.17%326030.KSSK Biopharmaceuticals Co., Ltd.$79,000.00+1.80%141080.KQLigaChem Biosciences Inc.$87,500.00+12.32%069620.KSDaewoong Pharmaceutical Co., Ltd$113,800.00-9.25%006280.KSGC Biopharma Corp.$115,900.00+1.49%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy